What is Isomorphic Labs?
Isomorphic Labs is a drug-discovery company spun out of Google DeepMind, led by Demis Hassabis, that builds on the protein-structure prediction breakthroughs of AlphaFold. It raised $2.1 billion in May 2026 in one of the largest funding rounds in AI drug discovery to date.
Answered in
Hassabis Left DeepMind's Day-to-Day to Build the Drug Engine Beyond AlphaFoldDemis Hassabis stepped back from running DeepMind to lead Isomorphic Labs full-time, where a $2.1 billion bet is turning AlphaFold into actual drugs.
Read the full analysisOther questions this article answers
More how ai actually works questions
- Why did OpenAI shut down Sora?
- Is Google Veo 3.1 free to use?
- What is Kling AI and why is it significant?
- What makes ByteDance's Seedance 2.0 different from other AI video tools?
- What is the Isomorphic Labs Drug Design Engine?
- Why did Hassabis step back from DeepMind?
- What is AlphaFold and why does it matter for drug discovery?
- What is Nvidia's Vera Rubin platform designed for?
Every answer on Crashtech is written by the editor of the article it comes from — never auto-summarised. Browse all answers or the How AI Actually Works beat.